Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bolte

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Ebiomedicine|August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanomaNiccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
BMC Cancer|February 22, 2023
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanomaAlessia Visconti, Niccolò Rossi, Helena Deriš, et al.
Nature Medicine|March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaKarla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature Medicine|February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanomaJohannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Ebiomedicine|August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanomaNiccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
BMC Cancer|February 22, 2023
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanomaAlessia Visconti, Niccolò Rossi, Helena Deriš, et al.
Nature Medicine|March 1, 2022
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaKarla A Lee, Andrew Maltez Thomas, Laura A Bolte, et al.
Nature Medicine|February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanomaJohannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Cell|June 21, 2024
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcomeLisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, et al.
Pageof 12